Last checked at 30 Mar 2022 18:01
NatWest Group plc | ||||||
30 March 2022 |
| |||||
Transaction in Own Shares | ||||||
NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1 each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). |
| |||||
|
|
|
|
|
|
|
Aggregated information: |
|
|
|
|
| |
|
|
|
|
|
|
|
Date of purchase | Number of Ordinary Shares purchased | Highest price paid: (GBp) | Lowest price paid: (GBp) | Volume weighted average price paid per share (GBp) | Venue |
|
30 March 2022 | 5,091,629 | 223.30 | 219.30 | 220.9187 | LSE |
|
30 March 2022 | 1,546,789 | 223.50 | 219.30 | 221.1493 | CHIX |
|
30 March 2022 | 1,443,021 | 223.40 | 219.30 | 220.9271 | BATE |
|
|
|
|
|
|
|
|
Such purchases form part of the Company's existing share buyback programme (the "Programme") and were effected pursuant to the instructions issued by the Company to UBS on 18 February 2022, as announced on 18 February 2022. |
| |||||
|
|
|
|
|
|
|
The Company intends to cancel the repurchased Ordinary Shares. | ||||||
|
|
|
|
|
|
|
Following the settlement of the above transactions, NWG will hold 146,116,846 Ordinary Shares in treasury and have 10,629,115,205 Ordinary Shares in issue (excluding treasury shares). |
| |||||
|
|
|
|
|
|
|
We announced on 21 February 2022 that the maximum number of Ordinary Shares that could be purchased by NWG under the Programme was 817,046,082. Such number of Ordinary Shares reflected the impact on the authority (the "2021 Authority") granted by shareholders to the Board of NWG at its Annual General Meeting, held on 28 April 2021, of: (i) the reduction in the Company's issued share capital following the off-market buyback announced on 19 March 2021; and (ii) the number of shares purchased by the Company under its previous share buyback programme announced on 30 July 2021. Following the Company's announcement on 28 March 2022 of the off-market purchase of Ordinary Shares from Her Majesty's Treasury, the maximum number of Ordinary Shares that may now be purchased by the Company under the Programme has been reduced further to 762,060,968.
Further information: | ||||||
|
|
|
|
|
|
|
Investor Relations |
|
|
|
|
|
|
+ 44 (0)207 672 1758 |
|
|
|
|
| |
|
|
|
|
|
|
|
Media Relations |
|
|
|
|
|
|
+44 (0)131 523 4205 |
|
|
|
|
| |
|
|
|
|
|
|
|
Legal Entity Identifier: 2138005O9XJIJN4JPN90 | ||||||
|
|
|
|
|
|
|
Transaction details |
|
|
|
|
| |
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme is available here: http://www.rns-pdf.londonstockexchange.com/rns/6686G_1-2022-3-30.pdf |
| |||||